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OBJECTIVE—Ethnicity has been identiﬁed as a risk factor not only for having type 2 diabetes
but for increased morbidity and mortality with the disease. Current American Diabetes Associ-
ation (ADA) guidelines advocate screening high-risk minorities for diabetes. This study inves-
tigates the effect of minority status on diabetes screening practices in an ambulatory, insured
population presenting for yearly health care.
RESEARCHDESIGNANDMETHODS—Thisisaretrospectivepopulation–basedstudy
of patients in a large, Midwestern, academic group practice. Included patients were insured, had
$1 primary care visit yearly from 2003 to 2007, and did not have diabetes but met ADA criteria
forscreening.Oddsratios(ORs),95%conﬁdenceintervals(CI),andpredictedprobabilitieswere
calculated to determine the relationship between screening with fasting glucose, glucose toler-
ance test, or hemoglobin A1c and patient and visit characteristics.
RESULTS—Of the 15,557 eligible patients, 607 (4%) were of high-risk ethnicity, 61% were
female, and 86% were $45 years of age. Of the eight high-risk factors studied, after adjustment,
ethnicity was the only factor not associated with higher diabetes screening (OR = 0.90 [95% CI
0.76–1.08]) despite more primary care visits in this group. In overweight patients ,45 years,
where screening eligibility is based on having an additional risk factor, high-risk ethnicity (OR
1.01 [0.70–1.44]) was not associated with increased screening frequency.
CONCLUSIONS—In an insured population presenting for routine care, high-risk minority
status did not independently lead to diabetes screening as recommended by ADA guidelines.
Factors other than insurance or access to care appear to affect minority-preventive care.
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O
ver the past decade, public aware-
ness of health care disparities in
the U.S. has increased. Congress
passed the Minority Health and Health
Disparities Research and Education Act
of 2000, which established the National
Center on Minority Health and Health
Disparities to study health care inequal-
ities in this country (1). The U.S. Depart-
ment of Health and Human Services
(USDHHS) Healthy People 2010 pro-
posal determined the issue of disparities
to be so important that eliminating health
care disparities was one of only two com-
prehensivehealthgoalstobeaddressedin
the past decade (2). Despite these efforts,
the 2008 National Healthcare Disparities
Report (NHDR) showed that, in minority
groups and the poor, 60% of reported
quality measures are not improving. The
reasons that health care disparities persist
are not always apparent and likely multi-
factorial but clearly affect patients with a
variety of medical conditions, including
type 2 diabetes, a disease that has reached
epidemic proportions in this country. In
multiple studies, ethnicity has been iden-
tiﬁed as a risk factor not only for having
type 2 diabetes but for increased morbid-
ity and mortality with the disease (3).
However, factors, such as lack of both
health care insurance and access to care
(3,4), which occur at higher rates in mi-
nority patients, may contribute to these
ﬁndings. There are limited data investi-
gating type 2 diabetes case ﬁnding in gen-
eral, with only minimal data including a
minority population that is both insured
andalsopresenting forhealthcare. Lower
screening rates in such a population
would suggest that factors other than in-
surance and access to care are affecting
minority diabetes testing, such as a de-
creased recognition that minority status
itself is a risk factor for type 2 diabetes,
poorer systems for ensuring screening
in clinics caring for predominantly mi-
nority patients, unconscious bias, or
patient-speciﬁc/cultural factors.
T h eA m e r i c a nD i a b e t e sA s s o c i a t i o n
(ADA) has established high-risk ethnicity
as one of 10 independent risk factors that
shouldnotonlytriggerdiabetesscreening
in overweight patients ,45 years (5) but
should also identify minority patients as
a high priority for screening at all ages.
We previously performed a retrospective
analysis of diabetes screening practices in a
large, Midwestern, academic physician
group for the 3-year period (1 January
2005–31 December 2007) (6), using the
Wisconsin Collaborative for Healthcare
Quality (WCHQ) criteria (7). Of eight
ADA-identiﬁed high-risk factors that
could be measured from the data, high-
risk minority status was associated with
the lowest screening rates (6). In addition,
once screened, these patients had a com-
paratively higher rate of diagnosis, con-
ﬁrming the importance of screening in
this group (6). However, the reasons for
this lower screening rate are unknown.
The proposed study examines whether
high-riskminoritystatustriggereddiabetes
screeningindependentofotherclinicalfac-
tors in an insured, ambulatory population
presenting for primary care.
RESEARCH DESIGN AND
METHODS
Background and data
This study was approved by the Univer-
sity of Wisconsin-Madison Health Sci-
ences institutional review board.
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ORIGINAL ARTICLEThe methods used in this study were
adapted from methods described previ-
ously (6). In brief, patients included were
$20 years of age on 1 January 2005 and
had at least one family practice or internal
medicine visit to the physician group in
eachofthe3studyyears,2005,2006,and
2007, in addition to a yearly visit in each
of the 2 preceding years, 2003 and 2004.
A 3-year period from 2005 to 2007 was
chosen based on ADA recommendations
to screen every 3 years (5). Data from
years 2003 and 2004 were used to deter-
mine prior diagnosis of diabetes, predia-
betes, preexisting comorbidities, and
pregnancy and to determine visit eligibil-
ity. Patients with any visit for pregnancy
in the years 2003 to 2007 were excluded,
as were patients who died during the 3-
year study period. Patients with two or
more outpatient encounters with a diag-
nosisofdiabetesintheyears2003to2004
were excluded, as were patients without
health care insurance.
Primary data retrieval
Patients’ clinical, laboratory, encounter,
and demographic information were ob-
tained from the electronic health record
of a large, Midwestern, academic physi-
cian group as described previously (6).
For all patients, data were extracted on
age, sex, ethnicity, BMI, evaluation and
management (E/M) outpatient encounter
data, provider specialty, and laboratory
data. In addition, we abstracted fasting
plasma glucose (FPG), random glucose
(RG), 2-h glucose tolerance test (GTT),
and hemoglobin A1c (HbA1c). Glucose
laboratory tests were classiﬁed as FPG if
theywerelabeledasfastingorweredrawn
at the same time as a fasting LDL or tri-
glyceride level per institution protocol.
These fasting tests, in addition to GTTs
and HbA1c, were considered the screen-
ingtestsforthisanalysis.AlthoughHbA1c
was not an accepted test for diabetes
screening during the study years, it was
included in our screening proﬁle and
used in the sensitivity test since it is
known that providers used HbA1c for
this purpose because of its recent incor-
poration into guidelines (5).
Variable deﬁnitions
Eight high-risk variables were deﬁned
based on the ADA-designated risk factors
for screening (5). These factors include
$45yearsofage,ethnicity,hypertension,
hypercholesterolemia, polycystic ovarian
syndrome(PCOS),vasculardisease,over-
weight (BMI $25 kg/m
2), and history of
prediabetes. The ADA risk factors of
ﬁrst-degree family history, physical inac-
tivity, and other clinical conditions asso-
ciatedwithinsulinresistancecouldnotbe
obtained. Deﬁnitions for high-risk vari-
ables were determined based on a combi-
nation of one or more factors, including
validated International Classiﬁcation of
Diseases, 9th Revision (ICD-9) codes
(8), laboratory data, and clinical informa-
tion, with detailed criteria for each high-
risk factor listed previously (6). In brief,
diagnosis of hypertension, PCOS, pre-
diabetes, and vascular disease was de-
termined by presence of two validated
diagnosis codes on two separate occa-
sions within 2 years by previously estab-
lished criteria (6). Age was determined as
the age as of 1 January 2005; overweight
was determined by having two ICD-9
codes by the same criteria above or if
last listed BMI was $25 kg/m
2; and hy-
percholesterolemia was also deﬁned by
t h ep r e s e n c eo ft w oI C D - 9c o d e so rb y
the presence of abnormal laboratory tests
(6). Patients with a listed ethnicity of
African American, Latino, Native Ameri-
can, Asian American, or Paciﬁc Islander
were designated as high-risk minorities.
Using the deﬁned high-risk factors,
the population meeting ADA screening
criteria was determined. This included
any patient $45 years of age or any over-
weightpatient,45yearswithatleastone
additional high-risk factor (5). The num-
ber of eligible patients screened was de-
termined. Because screening for patients
,45 years should be triggered by the
presence of at least one high-risk factor in
addition to obesity, a separate analysis of
patients in this category was conducted.
Statistical analysis
Data were analyzed using Stata version
10.0 (9). Categorical variables were sum-
marized using percentages. Continuous
variables were summarized using means
and SD. Multivariable logistic regression
was used to estimate adjusted odds ratios
(ORs), predicted probabilities, and 95%
CI for relationships between diabetes
screening and patient and visit character-
istics. Predicted probabilities were calcu-
latedusingthemarginscommandinStata
and calculating the effects at the average
of the covariates. Predicted probabilities
were produced from a ﬁtted logistic re-
gression model where the outcome was
whether a subject would receive diabetes
screening. Therefore, from this model,
onecancalculatetheprobabilityofreceiv-
ingdiabetesscreeningatanygivenlevelof
covariates. Continuous variables were set
Table 1—Baseline patient characteristics of patients eligible for diabetes screening
(n = 15,557)*
Overall population
By risk group
P value High risk Not high risk
n 15,557 607 14,950 —
High-risk factors†
Age $45 years 86 66 87 ,0.001
High-risk ethnic group 4 —— —
Hypertension 45 48 45 0.149
Hypercholesterolemia 70 52 71 ,0.001
Polycystic ovarian syndrome ,1 ,1 ,10 . 7 0 3
Prediabetes ,1 ,1 ,10 . 9 0 0
Vascular disease 10 9 11 0.118
Overweight 67 72 67 0.012
Sex 0.256
Male 39 41 39 —
Female 61 59 61 —
Primary care specialty‡ 0.003
Internal medicine 46 2 44 —
Family practice 54 2 52 —
Number of visits, mean§
Primary care visits 9.13 (5.75) 10.78 (6.45) 9.06 (5.71) ,0.001
Specialty care visits 5.82 (7.10) 5.51 (7.28) 5.83 (7.09) 0.280
*Values represent percentages unless otherwise speciﬁed, and numbers in parentheses indicate standard
deviations; †high-risk factors generated from the ADA screening criteria, as deﬁned previously (6); ‡primary
carespecialtydeterminedforeachpatientbyspecialtyinwhichthemajority,orall,oftheirprimarycarevisits
occurred; §number of primary care, specialty, and total visits is mean number of visits per patient over the
time period 1 January 2005–31 December 2007.
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Diabetes case ﬁnding in minoritiesattheirmeans.Additionalmodelspredicted
FPG screening for patients with high-risk
and non–high-risk ethnic status and for
thesubsampleofobesepatients,45years
with an additional risk factor. As a sensi-
tivity analysis, all multivariable regression
models were also run using any glucose-
screeningtest.Thepresenceofprediabetes
a n dP C O Sw a sg i v e ni nl o wn u m b e r s
in the sample and was not used in analy-
ses. P values #0.05 were considered sta-
tistically signiﬁcant.
RESULTS—A total of 15,557 patients
were eligible for screening (Table 1). Of
these patients, 86% were $45 years of
age. Other than age, the most common
high-risk factor was hypercholester-
olemia (70%). Sixty-one percent were fe-
male, and patients were seen more often
by family practice providers (54%) than
byinternists(46%).Atotalof607(4%)of
patients were high-risk minorities, and
minorities hadsigniﬁcantlymoreprimary
care visits than nonminority patients
(10.78 vs. 9.06; P , 0.001) between
2005 and 2007. A total of 10,586 (68%)
of all eligible patients and 361 (59%) of
eligible high-risk ethnicity patients were
screened using FPG, GTT, or HbA1c.O f
the 10,586 screened patients, 9,999
(94%) had a fasting glucose identiﬁed by
concurrent LDL or triglyceride draw, 58
(0.5%) had independent FPG, 63 (0.6%)
had GTT, and 2,249 (21%) had HbA1c,
with many patients having more than
one of these tests drawn.
Of the ADA high-risk factors, only
high-risk ethnicity was not associated
with higher frequency of diabetes screen-
ing after adjustment for patient and visit
characteristics (OR 0.90 [95% CI 0.76–
1.08]) (Table 2). The predicted proba-
bility of screening was 68 and 66% for
non–high-riskandhigh-riskethnicgroups,
respectively. The number of primary care
visits (OR 0.99 [0.987–1.000]) and spe-
cialty visits (OR 1.00 [0.994–1.005]) did
not correlate with screening, and patients
eligible for screening who had internal
medicine primary care providers were as
likely to be tested (OR 1.04 [0.97–1.12])
as those who had family practice provid-
ers. When comparing screening for pa-
tients in non–high-risk and high-risk
ethnic groups, after adjustment, age $45
years (OR 1.55 [1.38–1.74]), overweight
status (OR 1.67 [1.54–1.81]), and male
sex (OR 1.33 [1.23–1.43]) were signiﬁ-
cant predictors of screening for non–
high-risk patients only (Table 3).
After adjustment, high-risk ethnic-
ity (OR 1.01 [95% CI 0.70–1.44]) and
vascular disease (OR 2.25 [0.86–5.91])
were not associated with increased fre-
quency of screening in patients ,45 years
who met screening criteria by virtue of
being obese and having an additional risk
factor (Table 4). Male sex signiﬁcantly pre-
dicted screening in this group (OR 1.36
[1.12–1.65]).
In a multivariate regression model
examining glucose testing by any method
(including random) and adjusting for
patient and visit characteristics, high-
risk ethnicity similarly was the only
ADA-designated high-risk factor that did
not lead to signiﬁcantly higher odds of
testing (OR 1.09 [95% CI 0.81–1.47]).
CONCLUSIONS—The main ﬁnding
of this study is that, in an insured pop-
ulation presenting for yearly primary care
visits, minority status is not being identi-
ﬁed as an independent risk factor for
diabetes screening as recommended by
the ADA guidelines (5). This ﬁnding is
most concerning in obese patients ,45
years, because screening in this subpopu-
lation depends on the presence and rec-
ognition of risk factors such as high-risk
ethnicity. Extensive data demonstrate
that minorities are more likely to have di-
abetes and to suffer comparatively in-
creased morbidity and worse glycemic
control (3,10,11), so these screening in-
adequacies are concerning.
National statistics and numerous
studies have demonstrated that health
care in minority patients is inferior to
care received by nonminority patients
(3,12).Althoughinequalitiesmaybemul-
tifactorial in etiology, data have consis-
tently suggested that lower rates of
Table 2—Unadjusted and adjusted ORs, predicted probabilities, and 95% CI for the
relationship between patient and visit characteristics and diabetes screening (n = 15,557)
OR 95% CI for
adjusted OR
Predicted
probability 95% CI Unadjusted Adjusted
High-risk factors†
Age $45 years
No 1.00 1.00 — 0.61 (0.59–0.63)
Yes 1.09 1.53* (1.37–1.70) 0.69 (0.68–0.70)
High-risk ethnic group
No 1.00 1.00 — 0.68 (0.63–0.69)
Yes 0.68 0.90 (0.76–1.08) 0.66 (0.63–0.70)
Hypertension
No 1.00 1.00 — 0.65 (0.64–0.66)
Yes 1.53* 1.48* (1.38–1.60) 0.72 (0.71–0.73)
Hypercholesterolemia
No 1.00 1.00 — 0.48 (0.47–0.50)
Yes 3.52* 3.59* (3.33–3.88) 0.76 (0.76–0.77)
Vascular disease
No 1.00 1.00 — 0.67 (0.67–0.68)
Yes 1.33* 1.33* (1.17–1.52) 0.73 (0.71–0.75)
Overweight
No 1.00 1.00 — 0.61 (0.60–0.62)
Yes 1.79* 1.67* (1.54–1.81) 0.71 (0.71–0.72)
Sex
Male 1.35* 1.30* (1.21–1.41) 0.71 (0.70–0.72)
Female 1.00 1.00 — 0.66 (0.65–0.67)
Primary care specialty‡
Family practice 1.00 1.00 — 0.68 (0.67–0.69)
Internal medicine 1.04 1.04 (0.97–1.12) 0.68 (0.67–0.70)
Number of visits§
Primary care 0.99 0.99 (0.987–1.000) 0.68 (0.67–0.69)
Specialty care 1.00 1.00 (0.994–1.005) 0.68 (0.67–0.69)
Adjustedforage,minoritystatus,hypertension,cholesterol,cardiovasculardisease,overweight,primarycare
specialty, number of primary care visits, and number of specialty visits. *Signiﬁcance at P , 0.05; †high-risk
factors generated from the ADA screening criteria, as deﬁned previously (6); ‡primary care specialty de-
termined for each patient by specialty in which the majority, or all, of their primary care visits occurred;
§number of primary care, specialty, and total visits is mean number of visits per patient over the time period
1 January 2005–31 December 2007.
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Sheehy and Associateshealth care insurance and resultant de-
creased access to care may be the largest
contributor to these disparities (13). In
2002, Finegold and Wherry (4) reported
that among U.S. adults aged 18–64 years,
20% of African Americans and 40.7% of
Hispanicswereuninsuredcomparedwith
12.4% of Caucasians. These inequalities
ininsurancecoveragecertainlycontribute
to suboptimal minority health care.
Becauseoftheknowneffectsofhealth
care insurance on minority care, the
current study includes only insured pa-
tients presenting for yearly primary care
visits to determine minority-screening
practices when health care access was
equal. We found that minority and non-
minority screening was equivalent. How-
ever, although equal care is appropriate
for many disease processes, the ADA rec-
ommends increased screening in high-
risk minority patients, particularly in
younger, overweight patients (5). There-
fore, even equivalent screening means that
minority patients are not being screened in
accordance with the ADA guidelines, de-
spite insurance and access being equal.
Our minority patients were notably seen
more frequently in clinics than nonminor-
ities, indicating that access was even more
robust in this subset of patients.
There are possible explanations for
these ﬁndings. First, providers may not
recognize that minority status is equiva-
lent to other stated ADA risk factors for
type 2 diabetes (3). It is notable that the
majority of other ADA risk factors in-
cluded in this study are comorbidities
typically treated with lifestyle modiﬁca-
tion and/or medication. The presence of
one of these typical cardiovascular risk fac-
torsmaybemorelikelytopromptaprovider
to seek early detection of other comorbidi-
ties,suchasdiabetes.Second,providersmay
seek to treat patients of all ethnic groups
equally and as a result ignore ethnicity as a
risk factor for diseases, such as type 2 diabe-
tes, where minority status should, in fact,
play a role in determining care. Third,
some providers may screen based on the
U.S. Preventive Services Task Force
(USPSTF) criteria, which do not factor eth-
nicityintoscreeningrecommendations(14).
Other reports have suggested that
unconscious bias may play a role in
minority inequalities (15). The Institute
of Medicine’s 2002 report, “Unequal
Treatment: Confronting Racial and Eth-
nic Disparities in Healthcare,” (16) high-
lighted the multifactorial nature of
disparities, along with the reality that un-
conscious bias may play a role in unequal
care.Althoughwecannotentirelyexclude
bias as a contributing factor in this study,
we saw no evidence that insured minori-
ties who presented for care had lower
rates of screening than nonminorities. It
is conceivable, however, that minorities
m a yh a v em o r ed i f ﬁculty returning to
clinic for what has traditionally been the
test of choice to diagnose diabetes, the
fasting glucose. This possibility suggests
that minority screening could be im-
proved with the ADA’s recent adoption
of the HbA1c into diagnostic criteria (5),
because this test can be performed in a
nonfasting state. Although datahavedem-
onstrated that HbA1c may perform differ-
ently in certain minority populations
(17,18), access to care and return for a
fasting laboratory test is also prohibitive
for some patients (19). Use of the HbA1c
may facilitate greater screening compli-
ance in a population that may be less
able to return for a follow-up fasting visit.
There are several limitations to this
study. First, although presence of hyper-
cholesterolemia was associated with sig-
niﬁcantly increased ORs for diabetes
screening in the sensitivity analysis, link-
ing glucose to fasting lipid panels in-
creased these ORs, which may have
introduced a selection bias. Second, al-
though this study included 15,557 pa-
tients, only 607 (4%) had high-risk
minority status. Screening practices in
thisstudymay notreﬂectwhat may occur
in a practice with a higher percentage of
minority individuals where providers
may be more aware of minority screening
recommendations. In addition, we could
not characterize income in this study.
Previous studies have suggested that in-
equalities in income and education, in-
dependent of ethnicity, may affect care
Table 3—Unadjusted and adjusted ORs and 95% CI for the relationship between patient and visit characteristics and diabetes
screening, by high-risk ethnic group status (n = 15,557)†
Non–high-risk ethnic group (n = 14,950) High-risk ethnic group (n = 607)
Unadjusted OR Adjusted OR
95% CI for
adjusted OR Unadjusted OR Adjusted OR
95% CI for
adjusted OR
High-risk factors‡
Age $45 years 1.03 1.55* (1.38–1.74) 1.54* 1.04 (0.66–1.66)
Hypertension 1.51* 1.48* (1.37–1.59) 2.06* 1.67* (1.14–2.45)
Hypercholesterolemia 3.42* 3.53* (3.26–3.82) 5.94* 6.01* (4.12–8.76)
Vascular disease 1.31* 1.31* (1.15–1.50) 2.17* 2.04* (1.003–4.153)
Overweight 1.83* 1.67* (1.54–1.81) 1.20 1.55 (0.99–2.43)
Sex
Male 1.36* 1.33* (1.23–1.43) 1.11 0.85 (0.58–1.23)
Female 1.00 1.00 — 1.00 1.00 —
Primary care specialty§
Family practice 1.00 1.00 1.00 1.00
Internal medicine 1.04 1.04 (0.96–1.12) 1.27 1.20 (0.82–1.74)
Number of visits||
Primary care 0.99 0.99 (0.987–1.000) 1.00 0.99 (0.96–1.02)
Specialty care 1.00 1.00 (0.993–1.004) 1.03* 1.02 (0.99–1.05)
*Signiﬁcance at P , 0.05; †high-risk ethnicities deﬁned as African American, Latino, Native American, Asian American, and Paciﬁc Islander; ‡high-risk factors
generated from the ADA screening criteria, as deﬁned previously (6); §primary care specialty determined for each patient by specialty in which the majority, or all, of
their primary care visits occurred; ||number of primary care, specialty, and total visits is mean number of visits per patient over the time period 1 January 2005–
31 December 2007.
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Diabetes case ﬁnding in minorities(20), although other studies such as the
National Health and Nutrition Examina-
tion Survey (NHANES) III demonstrated
that income and education were not re-
lated to incidence of undiagnosed diabe-
tes (21) or glycemic control. Given this
debate, it is less likely that income and
education play a role in our results, espe-
ciallyaswecontrolledforinsurancestatus
andincluded those whohadaccessed pri-
mary care.
Finally, as is the case with all admin-
istrative data, we were limited in which
variables we were able to include. Some
data suggest that factors, such as health
care literacy or medical mistrust, may
contribute to minority health disparities
(3), whereas other reports have not found
factors such as mistrust to play a major
role(22).Theliteraturehasalsosuggested
that minority patients may see less capa-
ble providers (23), that providers may
treatminoritiesdifferentlythantheirnon-
minority patients, and that minorities
may be seen more frequently at clinics
with fewer resources and more chaos
(24). All of these factors could affect
screening and cannot be entirely ex-
cluded.Althoughanecdotalevidencesug-
gests that providers intentionally order
fasting lipid panels and fasting glucoses
together, we cannot be entirely certain
with administrative data that providers
ordering a metabolic panel with a lipid
panel did this intentionally to obtain a
fasting, screening glucose.
In summary, this study represents a
comprehensive analysis of diabetes-
screening practices of insured minority
patients presenting for yearly primary
care visits in an ambulatory setting.
Most signiﬁcantly, this analysis demon-
strated that high-risk ethnicity patients,
despite higher frequency of clinic visits,
are not more likely to be screened com-
pared with nonminority patients with
similar risk factors, which is inconsistent
with current diabetes screening guide-
lines. Because minority status confers not
only increased risk of having type 2 di-
abetes but also risk for having increased
complications once diagnosed, it is criti-
cal that these screening inequalities are
identiﬁed and eliminated. Although per-
formance of HbA1c may be slightly differ-
ent compared with nonminorities, use of
HbA1cintheminoritypopulationmayin-
crease screening compliance, as this test
does not require a return fasting visit. In-
creased provider awareness of diabetes-
screening guidelines and implementation
of plans to remedy these ﬁndings may
help eliminate inequalities in diabetes
case ﬁnding.
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Table 4—Unadjusted and adjusted ORs, predicted probabilities, and 95% CI for the relationship between patient and visit
characteristics and diabetes screening in overweight adults aged 20–44 years (n = 2,160)†
Unadjusted OR Adjusted OR 95% CI for adjusted OR Predicted probability 95% CI
High-risk factors‡
High-risk ethnic group
No 1.00 0.66 (0.64–0.68)
Yes 0.53* 1.01 (0.70–1.44) 0.67 (0.60–0.74)
Hypertension
No 1.00 0.62 (0.59–0.65)
Yes 1.36* 1.98* (1.57–2.50) 0.75 (0.72–0.79)
Hypercholesterolemia
No 1.00 0.40 (0.34–0.46)
Yes 2.82* 3.94* (2.94–5.30) 0.71 (0.69–0.74)
Vascular disease
No 1.00 0.66 (0.64–0.68)
Yes 1.97 2.25 (0.86–5.91) 0.81 (0.67–0.95)
Sex
Male 1.49* 1.36* (1.12–1.65) 0.70 (0.67–0.73)
Female 1.00 0.64 (0.61–0.67)
Primary care specialty§
Family practice 1.00 0.65 (0.63–0.68)
Internal medicine 1.20 1.23 (0.99–1.53) 0.69 (0.66–0.73)
Number of visits||
Primary care 1.00 1.01 (0.99–1.02) 0.66 (0.64–0.68)
Specialty care 1.01 1.01 (0.99–1.03) 0.67 (0.65–0.69)
*SigniﬁcanceatP,0.05;†overweightdeﬁnedasBMI$25kg/m
2oroverweightorobeseperElixhausercriteria;‡high-riskfactorsgeneratedfromtheADAscreening
criteria, as deﬁned previously (6); §primary care specialty determined for each patient by specialty in which the majority, or all, of their primary care visits occurred;
||number of primary care, specialty, and total visits is mean number of visits per patient over the time period 1 January 2005–31 December 2007.
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